GPT and metabolic dysfunction-associated steatotic liver disease: In nonalcoholic fatty liver disease (NAFLD) and liver damage, enzymes of the liver that are typically detected in plasma, including aspartate transaminase (AST) and alanine transaminase (ALT), will pathologically increase [18].